Report: Lupin's generic Fortamet receives FDA nod

NEW DELHI — The Food and Drug Administration has approved a diabetes drug made by Lupin Pharmaceuticals, according to published reports.

The FDA approved Lupin’s metformin hydrochloride extended-release tablets, a generic version of Andrx Labs’ Fortamet.

Fortamet had sales of $83 million in 2010, according to IMS Health.

Login or Register to post a comment.